Literature DB >> 3141783

Characterization of a factor that stimulates hydrolysis of GTP bound to ras gene product p21 (GTPase-activating protein) and correlation of its activity to cell density.

M Hoshino1, M Kawakita, S Hattori.   

Abstract

The postmicrosomal fraction of the extract from NIH 3T3 and BALB/c 3T3 cells stimulated the hydrolysis of GTP bound to H-ras gene product p21 by severalfold. The stimulation was observed with normal p21 but not with p21 with valine as the 12th residue. This specificity is similar to that of GTPase-activating protein (GAP) for N-ras p21 described by M. Trahey and F. McCormick (Science 238:542-545, 1987). Consistent with this specificity, analysis of p21-bound nucleotides in living cells revealed that almost all normal p21 bound GDP, whereas oncogenic mutant p21s bound both GTP and GDP. Similar activity was also found in various mouse tissues, with brain tissue showing the highest specific activity. When cell extracts were prepared from cultured cells, there was a linear relationship between GAP activity and cell density. These results suggest the factor is involved in the regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141783      PMCID: PMC365486          DOI: 10.1128/mcb.8.10.4169-4173.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  ras proteins can induce meiosis in Xenopus oocytes.

Authors:  C Birchmeier; D Broek; M Wigler
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

2.  Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21.

Authors:  N Hagag; S Halegoua; M Viola
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

3.  Mutational analysis of a ras catalytic domain.

Authors:  B M Willumsen; A G Papageorge; H F Kung; E Bekesi; T Robins; M Johnsen; W C Vass; D R Lowy
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

4.  Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.

Authors:  S Hattori; L S Ulsh; K Halliday; T Y Shih
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

5.  Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide.

Authors:  J C Lacal; S A Aaronson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

7.  Identification of guanine nucleotides bound to ras-encoded proteins in growing yeast cells.

Authors:  J B Gibbs; M D Schaber; M S Marshall; E M Scolnick; I S Sigal
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

8.  Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.

Authors:  V Manne; E Bekesi; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation.

Authors:  D Bar-Sagi; J R Feramisco
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

10.  Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange.

Authors:  S Hattori; D J Clanton; T Satoh; S Nakamura; Y Kaziro; M Kawakita; T Y Shih
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

View more
  12 in total

Review 1.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.

Authors:  T Satoh; M Endo; M Nakafuku; S Nakamura; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis.

Authors:  Sudarshan Anand; Bharat K Majeti; Lisette M Acevedo; Eric A Murphy; Rajesh Mukthavaram; Lea Scheppke; Miller Huang; David J Shields; Jeffrey N Lindquist; Philip E Lapinski; Philip D King; Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2010-08-01       Impact factor: 53.440

4.  Inhibition by phospholipids of the interaction between R-ras, rho, and their GTPase-activating proteins.

Authors:  M H Tsai; A Hall; D W Stacey
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

5.  Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor.

Authors:  H Cen; A G Papageorge; W C Vass; K E Zhang; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3'-kinase in NIH 3T3 cells.

Authors:  J Ghai; R S Ostrow; J Tolar; R C McGlennen; T D Lemke; D Tobolt; Z Liu; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity.

Authors:  T Satoh; M Endo; M Nakafuku; T Akiyama; T Yamamoto; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Mechanism of the spatio-temporal regulation of Ras and Rap1.

Authors:  Yusuke Ohba; Kazuo Kurokawa; Michiyuki Matsuda
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

9.  Regulation of Ras signal transduction during T cell development and activation.

Authors:  Philip E Lapinski; Philip D King
Journal:  Am J Clin Exp Immunol       Date:  2012

10.  Insulin stimulation of gene expression mediated by p21ras activation.

Authors:  B M Burgering; R H Medema; J A Maassen; M L van de Wetering; A J van der Eb; F McCormick; J L Bos
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.